PHINMO contains the active substance fingolimod, which belongs to a group of medicines known as sphingosine - 1 - phosphate (S1 - P) receptor modulators. It is used in the treatment of relapsing (returning) multiple sclerosis (MS). PHINMO does not cure MS, but it helps to reduce the number of relapses (returns) that occur and to slow the build - up of physical problems due to MS (disability progression).
How PHINMO works
Multiple sclerosis (MS) is a long - term condition that affects the central nervous system (CNS), particularly how the brain and spinal cord work. In MS, inflammation destroys the protective sheath (called myelin) around the nerves in the CNS, and stops the nerves from working properly. PHINMO helps to fight against cells that cause inflammation from reaching the brain. This reduces nerve damage caused by MS.